Triptolide abrogates growth of colon cancer and induces cell cycle arrest by inhibiting transcriptional activation of E2F
Open Access
- 20 April 2015
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 95 (6) , 648-659
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- miR-204 mediated loss of Myeloid cell leukemia-1 results in pancreatic cancer cell deathMolecular Cancer, 2013
- Triptolide inhibits colon-rectal cancer cells proliferation by induction of G1 phase arrest through upregulation of p21Phytomedicine, 2012
- MAPKs Are Not Involved in Triptolide-Induced Cell Growth Inhibition and Apoptosis in Prostate Cancer Cell Lines with Different p53 StatusPlanta Medica, 2010
- Triptolide therapy for neuroblastoma decreases cell viability in vitro and inhibits tumor growth in vivoSurgery, 2009
- A Small-Molecule Triptolide Suppresses Angiogenesis and Invasion of Human Anaplastic Thyroid Carcinoma Cells via Down-Regulation of the Nuclear Factor-κB PathwayMolecular Pharmacology, 2009
- PG490-88, a derivative of triptolide, causes tumor regression and sensitizes tumors to chemotherapy.2003
- E2F and cell cycle control: a double-edged swordArchives of Biochemistry and Biophysics, 2003
- Triptolide inhibits the growth and metastasis of solid tumors.2003
- Role for the p53 homologue p73 in E2F-1-induced apoptosisNature, 2000
- Regulation of E2F1 activity by acetylationThe EMBO Journal, 2000